Department of Drug and Health Sciences, V.le A. Doria, 6, 95125 Catania, Italy
Office: +39 095/7384223
combine@combine-group.org

Author: Giulia Nicotra

๐Ÿ“ขย ๐‚๐š๐ฅ๐ฅ ๐Ÿ๐จ๐ซ ๐€๐›๐ฌ๐ญ๐ซ๐š๐œ๐ญ๐ฌ โ€“ ๐•๐๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ” | ๐๐Ž๐– ๐Ž๐๐„๐!

We are excited to share that ourย Group Leaderย Prof. Francesco Pappalardo serve asย Chair of the Track โ€œ๐˜Š๐˜ฐ๐˜ฎ๐˜ฑ๐˜ถ๐˜ต๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ข๐˜ญ ๐˜ข๐˜ฏ๐˜ฅ ๐˜ˆ๐˜-๐˜ฅ๐˜ณ๐˜ช๐˜ท๐˜ฆ๐˜ฏ ๐˜‹๐˜ณ๐˜ถ๐˜จ ๐˜‹๐˜ฆ๐˜ญ๐˜ช๐˜ท๐˜ฆ๐˜ณ๐˜บ ๐˜ข๐˜ฏ๐˜ฅ ๐˜‹๐˜ฆ๐˜ด๐˜ช๐˜จ๐˜ฏโ€ย at theย ๐Ÿ—๐ญ๐ก ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž ๐จ๐ง ๐ญ๐ก๐ž ๐•๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐๐ก๐ฒ๐ฌ๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐‡๐ฎ๐ฆ๐š๐ง (๐•๐๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”) This is a fantastic opportunity to contribute and engage in discussions on computational and AI-driven approaches in drug delivery and drug design, within…
Read more

Combine Group at the Union World Conference on Lung Health 2025 โ€“ Copenhagen

We are pleased to announce that Prof. Francesco Pappalardo, Leader of the Combine Group, was officially invited to speak at the Union World Conference on Lung Health 2025, one of the most influential global events dedicated to tuberculosis and respiratory health. During the conference, Prof. Pappalardo delivered a presentation titled:โ€œIn Silico Trials to Identify and…
Read more

Prof. Francesco Pappalardo delivers keynote at the 2nd International Annual Conference on Artificial Intelligence in Health (AI Health 2025)

On November 10th, 2025, our Group Leader Prof. Francesco Pappalardo delivered a keynote lecture at the 2nd International Annual Conference on Artificial Intelligence in Health (AI Health 2025). In his talk, titled โ€œThe evolving landscape of in silico medicine and its growing recognition by regulatory bodiesโ€, Prof. Pappalardo explored how in silico medicine is gaining increasing acknowledgment from international regulatory authorities, with a…
Read more

In silico medicine is no longer the future, itโ€™s the present.

In recent years, biomedical research has been undergoing a silent but powerful transformation.A recent Nature article โ€œAlternatives to animal testing are the futureโ€ sends a clear message: itโ€™s time to move beyond animal testing and embrace approaches that are more ethical, predictive, and human-centered. At the forefront of this shift stands in silico medicine the use of computational models and digital simulations to…
Read more

๐‚๐ž๐ฅ๐ž๐›๐ซ๐š๐ญ๐ข๐ง๐  ๐Ÿ๐ŸŽ ๐ฒ๐ž๐š๐ซ๐ฌ ๐จ๐Ÿ ๐ฉ๐ซ๐จ๐ ๐ซ๐ž๐ฌ๐ฌ ๐ญ๐จ๐ฐ๐š๐ซ๐ ๐š๐ง๐ข๐ฆ๐š๐ฅ-๐ญ๐ž๐ฌ๐ญ๐ข๐ง๐ -๐Ÿ๐ซ๐ž๐ž ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง!

We are excited to share that on 5โ€“6 November 2025, Brussels will host the 20th Anniversary Conference of the European Partnership for Alternative Approaches to Animal Testing (EPAA).For two decades, the EPAA has united the European Commission, industry, academia, and NGOs around one shared goal: promoting the โ€œ3Rsโ€ โ€” Replacement, Reduction and Refinement โ€” in…
Read more

UISS al Parlamento Europeo: lโ€™eccellenza scientifica โ€œmade in UniCTโ€ protagonista a Bruxelles!ย 

Il progetto UISS โ€“ Universal Immune System Simulator, sviluppato dal Prof. Francesco Pappalardo con il supporto del Gruppo COMBINE del Dipartimento di Scienze del Farmaco e della Salute dellโ€™Universitร  di Catania, รจ stato recentemente presentato al Parlamento Europeo durante โ€œExcellence in Health Scienceโ€, evento promosso dal Committee on Public Health (SANT). A rappresentarlo, la prof.ssa Liesbet Geris (KU Leuven, Universitรฉ de Liรจge), direttrice esecutiva della Virtual Physiological…
Read more